Structure

InChI Key BPZSYCZIITTYBL-YJYMSZOUSA-N
Smile COc1ccc(C[C@@H](C)NC[C@H](O)c2ccc(O)c(NC=O)c2)cc1
InChI
InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C19H24N2O4
Molecular Weight 344.41
AlogP 2.22
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 4.0
Number of Rotational Bond 9.0
Polar Surface Area 90.82
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 25.0

Pharmacology

Primary Target
β2-adrenoceptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Asthma 3 D001249 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 3 D029424 ClinicalTrials
Emphysema 3 D004646 ClinicalTrials
Bronchitis, Chronic 3 D029481 ClinicalTrials
Bronchial Spasm 3 D001986 ClinicalTrials
Bronchitis 3 D001991 ClinicalTrials

Related Entries

MCS

Scaffolds

Salt

Cross References

Resources Reference
CAS NUMBER 67346-49-0
ChEBI 408174
ChEMBL CHEMBL1363
DrugBank DB01274
DrugCentral 4943
EPA CompTox DTXSID1023077
FDA SRS F91H02EBWT
Human Metabolome Database HMDB0015399
Guide to Pharmacology 7479
PDB H98
PharmGKB PA164743977
PubChem 3083544
SureChEMBL SCHEMBL4247
ZINC ZINC000002599970